NovaBay Pharmaceuticals, Inc. Signs Avenova And NeutroPhase Distribution Agreements
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products, today announced that it has signed two new distribution agreements to market its products in international markets.
Sarmedic Ltd will have exclusive rights to market and distribute NovaBay’s innovative eye care product Avenova™ in Israel. Alpha Pharma LLC will have exclusive rights to market and distribute NovaBay’s wound cleanser NeutroPhase® in the Ukraine.
Help employers find you! Check out all the jobs and post your resume.
Sarmedic Ltd will have exclusive rights to market and distribute NovaBay’s innovative eye care product Avenova™ in Israel. Alpha Pharma LLC will have exclusive rights to market and distribute NovaBay’s wound cleanser NeutroPhase® in the Ukraine.
Help employers find you! Check out all the jobs and post your resume.